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INTRODUCTION 
Sickle cell disease is an inherited 
hemoglobinopathy.1 James Herrick, was the first to 
describe sickle shaped red blood cells (RBCs) in 
1910. Linus Pauling et al. reported altered 
electrophoretic mobility of sickle haemoglobin 
(HbS) in 1949. A few years later, Vernon Ingram in 
1957 described its pathophysiology as, when 6th 
amino acid Glutamic acid of ß chain of Globin 
(HbA) is replaced by another amino acid Valine 
(HbS) at 11 chromosome of sickle haemoglobin.2 
The life span of RBCs in such patients is only about 
10 to 20 days and the bone marrow is not able to 
form new RBCs to replace rapidly destroying sickle 
RBCs resulting in hypochromic anemia. Crescent 
shaped RBCs have reduced elasticity causing them 
to become stiff, sticky which readily blocks blood 
flow in small capillaries. Blocking of blood flow 
results in ischemia which leads to severe pain and 
gradual damage to organs. Sickle cell disease has 
various forms like: homozygous sickle cell anemia 
(HbSS); sickle cell C disease(HbSC); sickle /beta 
thalassemia and other compound heterozygous 
conditions. Homozygous form of it is the most 
severe form clinically. 
 
The genes for the beta globin chains are inherited 
as per mendalian’s law when mutation inherited 
in a heterozygous manner, the individual receives 
only   one  gene codifying   for HbS.  This  defect is  
 
known as sickle cell trait (SCT). It is a carrier state 
and more common than homozygous sickle cell 
disease (HbSS).1 Prevalence of  Sickle cell gene was 
first described by Lehmann and Cutbush in 1952 
among South Indian tribal people.3 By 
Anthropological Survey of India (Negi 1972)4, 
sickle cell trait frequency of upto 35% reported 
mainly throughout of central India, like in Orissa, 
Chhattisgarh, Madhya Pradesh, Maharashtra and 
Gujrat (Balgir 1996: Ambedker et al. 2001)5,6 
frequency of sickle cell disease in Orissa and 
Chhattisgarh were found to be approximately 10% 
and 9% respectively. 
 
At capital of Chhattisgarh state, Raipur a 
screening survey was conducted by Parta et 
al(2011).7 Results showed that the prevalence of 
sickle cell disease was 2.1% whereas sickle cell trait 
was 10% among different tribes with the majority 
of cases reported in Agharia, Kurmi, Teli and Sahu, 
Panika.8 (Table 1, Figure 1) 
 
PATHOPHYSIOLOGY 
It occurs due to single aminoacid substitution at 
6th position of ß chain amino acid where Glutamic 
acid of of Globin (HbA) is replaced by another 
amino acid Valine (HbS) at 11 chromosome. This 
leads to formation of HbS which undergoes 
polymerization when deoxygenated, the main 
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event of sickle cell pathology. Rate of 
polymerisation depends on intra-erythrocytic HbS 
concentration, haemoglobin deoxygenation rate 
and its pH. The resultant rope like polymer aligns 
to form a bundle causing distortion of red blood 
cells into characteristic sickle shaped RBCs. 
(Figure 2,3). These altered sickle red cells have 
reduced elasticity which sticks and occludes the 
circulation in small diameter capillaries causing 
infarction of organs leading to painful cramps. 
Haemolysis and vaso-occlusion are two main 
pathological changes noted in sickle cell disease. 
Haemolysis leads to hypochromic, hypovolemic 
anaemia with a functional deficiency of nitric 
oxide causing vascular endothelial damage which 
results in complications like pulmonary 
hypertension and stroke. Acute and chronic 
ischaemia due to vaso-occlusion is responsible for 
acute pain and organ damage. Signs and 
symptoms seen not only in homozygous sickle cell 
disease but also in compound heterozygous forms 
associated with HbC, HbS, ß-thalassemia, HbE, 
and HbO.9 
 
INHERITANCE PATTERN  
When both the parents have sickle cell trait, each 
child has a 50 percent chance of inheriting two 
sickle cell trait; a 25 percent chance of inheriting 
sickle cell disease; and a 25 percent chance of 
being normal without any disease (Figure 4). 
 
DENTAL MANIFESTATIONS 
As per Mendes et al. (2011)10, orofacial signs and 
symptoms noticed in sickle cell disease patients 
are as followings:- 
1. Pallor of oral mucosa 
2. Delayed tooth eruption 
3. Dental hypoplasia 
4. Atropy of tongue papillae 
5. Intrinsic tooth opacity 
6. Maxillary protusion 
7. Recurrent mandibular pain 
8. Mental nerve neuropathy  
9. Mandibular osteomyelitis  
10. Toothache 
 
Occasionally, this disease may cause mandibular 
infarcts which may be mistaken as osteomyelitis.11 
 
Kaya et al.12 reported that sickle cell disease may 
cause pulp necrosis in those patients who had no  
past history of trauma or any dental restorations. 
Sometimes, following sickle crisis, due to 
infarction of microvasculature of inferior alveolar 
nerve or its branches may cause permanent 
neuropathies.13 More recently, Scipio et al.14 
reported acute facial swelling, gingival 
enlargement as a result of repeated haemorrhagic 
episodes and fibrous repair. 
 
DIAGNOSIS OF SICKLE CELL DISEASE  
Complete blood count (CBC) helps to identify the 
underlying bleeding disorders. Sickle shaped cells 
seen in blood smears, which varies from few to 
40% of all red cells.  
 
MANAGEMENT OF SICKLE CELL CRISIS  
For moderate to severe pain, analgesic agent like 
morphine SC/IV should be started as soon as 
possible and may be continued as infusion till 
required. Moderate pain may be controlled by 
regularly administered oral codeine or oral 
morphine. Nonsteroidal anti-inflammatory 
analgesia and paracetamol should always be given 
unless there is renal or hepatic impairment, and 
may be sufficient for mild crisis.  
 
 Fluid replacement by intravenous fluids at a 
rate of 80-100ml/kg/24 hours should be used.15 
 Oxygen therapy:- 100% oxygen should be 
given, if O2  saturation <95%.  
 
Antibiotics: Intravenous antibiotics like 
cefotaxime (50mg/kg TID) or IV ceftriaxone 
(50mg/kg OD) should be started, if patient is 
febrile >38 Centigrade. Oral antibiotics could be 
started if condition improves.16 
  
Blood Transfusion: Most of the patients with 
sickle cell disease are asymptomatic with 
haemoglobin of 6-7gm%, so, should not require 
transfusion. In symptomatic patients, where 
haemoglobin is less than 6gm%, transfusion is 
needed. Only in severe cases of sickle crisis like 
acute chest syndrome or cerebrovascular event, 
exchange transfusion should be considered under 
supervision of haematologist.  
 
Exchange transfusion may be required pre-
operatively for certain surgical procedures (e.g., 
eye surgery and neurosurgery). Disease-modifying 
treatments should be used when there are 
frequent pain episodes or life-threatening events. 
Patients with severe complications, such as stroke 
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and CNS complications, are usually transfused on 
a regular basis to reduce their HbS concentration 
(aim <30%) and to ensure a high haemoglobin 
level (11-12gm%).17 
  
Hydroxyurea: This increases HbF levels, reduces 
lymphocytes and platelet count which in turn 
increases nitric oxide production, causing 
reduction in frequency and aggressiveness of 
sickle cell events. 
 
Stem cell transplantation (SCT) is considered only 
when patients are not responding to other 
treatments, and if a HLA-compatible sibling donor 
is available. Matched unrelated SCT can also be 
performed; however, transplant-related mortality 
is higher than with sibling donor transplant.  
 
Prophylaxis: In addition to routine vaccinations, 
patients with SCD require specific vaccination. All 
individuals with SCD have reduced splenic 
function and therefore reduced capacity to kill 
encapsulated bacteria. All patients should receive 
vaccination against Pneumococcus pneumoniae. 
Long-term daily use of oral penicillin is 
recommended. If liquid medication is used in 
children, then a sugar-free medication should be 
prescribed to minimize incidence of dental caries. 
As Sickle cell diseased patients undergo multiple 
blood transfusion during their life; therefore, 
hepatitis B vaccination is also recommended. Folic 
acid is also recommended for prolonged duration 
of use because of increased demand due to the 
high turnover of RBCs (haemolysis). 
 
General anaesthesia: Koshy et al.18 divided 
surgical procedures based on the risk in sickle 
diseased patients into three groups as follows: 
Low-risk procedures such as dental surgery, eyes, 
skin, extremities, perineal and inguinal surgery; 
Moderate risk procedures like genito-urinary 
system, intra-abdominal areas, tonsillectomy, 
caesarean section, splenectomy, cholecystectomy, 
hip replacement; High-risk procedures like intra-
cranial, cardiovascular and intrathoracic surgery. 
 
DENTAL MANAGEMENT OF SICKLE CELL 
DISEASE PATIENT 
Prevention of dental disease to prevent occurrence 
of acute infection, which might trigger sickle cell 
crisis. In very young children, general anaesthesia 
should be avoided for elective dental treatment. A 
prophylactic preventive regime should be 
instituted in all such patients. Routine dental 
visits are recommended during eruption age of 
deciduous teeth. Advice and information should 
be given to prevent caries. Thereafter, patients 
should attend their dentist at least twice yearly, for 
fluoride varnish application, preventive advice 
and ongoing dental care throughout adulthood. 
Patients who have compromised splenic function 
should have antibiotics prescribed at the time of 
oral surgical procedures due to associated 
increased risk of local or systemic infections. If 
dental infection occurs, it must be promptly and 
adequately treated, as acute infections may trigger 
sickle crisis. 
 
Conscious sedation may be used to manage 
anxiety during treatment under local anaesthesia. 
Dental treatment under conscious sedation or 
general anaesthesia should be done in a hospital 
setup where haematology expertise is available.19 
 
DISCUSSION  
Sickle cell disease carries ASA III anesthetic risk. 
Thus, Local anesthesia is generally preferred over 
general anesthesia for treating such patients as it 
does not lower the oxygenation of blood.  
 
Among various types of local anesthetic agents, 
Lidocaine 2% with a vasoconstrictor like 
adrenaline 1:80,000 is preferred for routine 
extraction procedures.20 Prophylactic invasive 
surgeries like extraction of deeply impacted third 
molars, orthognathic surgeries should be avoided. 
Conscious sedation (nitrous oxide-oxygen) proved 
useful in pediatric patients with > 50% oxygen of 
high flow rate and adequate ventilation. In case, if 
general anesthesia is required, before its 
induction, proper hemoglobin levels should be 
obtained through transfusions, 10 to 15 days before 
the  operation.  Symptomatic    patients with    Hb  
<6gm% require blood transfusion. Optimum 
hemoglobin levels obtained after blood 
transfusions should lie in the range of 10-12 gm% 
for children and 8-10 gm% for adults. Inhalation 
sedation is safe, as a minimum of 50% oxygen is 
used (much higher than room air oxygen). At the 
termination of nitrous oxide administration, 100% 
oxygen should be administered for approximately 
five minutes, to prevent rapid exhalation of 
nitrous oxide and the potential development of 
diffusion hypoxia. Prevent postoperative 
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dehydration by giving IV normal saline (80-
100ml/kg/24 hrs) and Ringer’s Lactate solution is 
not preferable as lactate causes lactic acidosis.  
 
Prophylactic Guidelines: A long term daily 
regimen of folic acid (5mg/day) should be given. 
Always schedule short term, morning dental 
appointments.For mild to moderate pain, use 
acetaminophen because salicylates may induce 
acidosis. Avoid elective surgery, like removal of 
asymptomatic impacted teeth. Incorporate home 
fluoride, fissure sealant therapy into the 
preventive dental treatment regimen.17,21 
 
CONCLUSION  
Patients having history of sickle 
haemoglobinopathy or from geographical areas 
where Sickle Cell Disease is prevalent, should be 
screened for it. A screening sickle solubility test 
(such as sickle-dex) should be arranged. If the 
results of this screening test are positive, then 
specific tests under the guidance of haematologist 
will be required to determine if SCT or SCD is 
present. No specific guidelines are required for 
dental treatment of sickle cell trait patients. 
However, if dental treatment under general 
anaesthesia is required for homozygous sickle cell 
patient, it should always be done in a hospital 
setup with expert haematologist. 
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Table 1. Percentages of various castes admitted with sickle cell disease in hospital  
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Figure 1. Distribution of carriers of sickle cell gene in various castes of Chattisgarh  
Figure 2. Pathophysiology of sickle cell disease 
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Figure 3. Pathophysiology of sickle cell disease 
Figure 4. Inheritance pattern of sickle cell disease 
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